Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Altaire Pharms., Inc. v. Paragon Bioteck, Inc., 17-1837 (E.D.N.Y.) Mar. 31, 2017 Hon. William F. Kuntz, II phenylephrine HCl ophthalmic solution 8,859,623
Mallinckrodt IP v. B. Braun Medical Inc., 17-0365 (D. Del.) Apr. 3, 2017 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012 6,992,218
Mallinckrodt IP v. B. Braun Medical Inc., 17-1521 (E.D. Pa.) Apr. 4, 2017 Hon. Jeffrey L. Schmehl Ofirmev® (acetaminophen for injection) 9,399,012 6,992,218
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01100 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 8,853,260
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01101 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01103 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Actavis LLC v. Abraxis Bioscience, LLC, IPR2017-01104 (PTAB) Apr. 4, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
Bristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc., 17-0374 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Breckenridge Pharm., Inc., 17-0375 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Hetero USA Inc., 17-0376 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Invagen Pharms., Inc., 17-0377 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Lupin Ltd., 17-0378 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Mylan Pharms. Inc., 17-0379 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sunshine Lake Pharma Co., Ltd., 17-0380 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Torrent Pharms. Ltd., 17-0381 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Unichem Labs., Ltd., 17-0382 (D. Del.) Apr. 5, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Gilead Sciences, Inc. v. Amneal Pharms., LLC, 17-2335 (D.N.J.) Apr. 6, 2017 Hon. Michael A. Shipp Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) 6,642,245 6,703,396 8,716,264
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 17-0389 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews Afinitor Disperz® (everolimus tablets) 5,665,772 8,778,962 8,617,598
Purdue Pharma L.P. v. Intellipharmaceutics Int’l Inc., 17-0392 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976 9,073,933 9,522,919 9,492,389 9,492,391 8,309,060
Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 17-0393 (D. Del.) Apr. 7, 2017 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 9,006,224 8,410,131 8,778,962 8,436,010
Dexcel Pharma Technologies Ltd. v. Apotex Corp., 17-2423 (D.N.J.) Apr. 7, 2017 Hon. Susan D. Wigenton omeprazole delayed-release tablets 9,023,391 7,255,878
Shire-NPS Pharms., Inc. v. Ambio, Inc., 17-0397 (D. Del.) Apr. 10, 2017 Hon. Gregory M. Sleet Gattex® (teduglutide for Injection) 7,056,886 7,847,061 9,060,992
Bristol-Myers Squibb Co. v. Accord Healthcare Inc., 17-0398 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Apotex, Inc., 17-0399 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945 6,413,980
Bristol-Myers Squibb Co. v. Bionpharma Inc., 17-0400 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Dr. Reddy’s Labs., Ltd., 17-0401 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Emcure Pharms. Ltd., 17-0402 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Impax Labs., Inc., 17-0403 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Indoco Remedies Ltd., 17-0404 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Macleods Pharms. Ltd., 17-0405 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Micro Labs USA Inc., 17-0406 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sandoz Inc., 17-0407 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sigmapharm Labs., LLC, 17-0408 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
Bristol-Myers Squibb Co. v. Sun Pharm. Indus. Inc., 17-0409 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc., 17-0410 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Wockhardt Bio AG, 17-0411 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Bristol-Myers Squibb Co. v. Zydus Pharms. (USA) Inc., 17-0412 (D. Del.) Apr. 10, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208 9,326,945
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 17-2448 (D.N.J.) Apr. 10, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122 7,456,160 8,329,680 8,466,139
Jazz Pharms., Inc. v. Amneal Pharms. LLC, 17-2452 (D.N.J.) Apr. 10, 2017 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,539,330
Novartis Pharms. Corp. v. Mylan Pharms. Inc., 17-0054 (N.D.W.V.) Apr. 10, 2017 Hon. Irene M. Keeley Afinitor Disperz® (everolimus tablets) 5,665,772 8,778,962 8,617,598
Celgene Corp. v. Zydus Pharms. (USA) Inc., 17-2528 (D.N.J.) Apr. 12, 2017 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800 7,855,217 7,968,569 8,530,498 8,648,095 9,101,621 9,101,622
Bristol-Myers Squibb Co. v. Mylan Pharms. Inc., 17-0055 (N.D.W.V.) Apr. 12, 2017 Hon. Irene M. Keeley Eliquis® (apixaban tablets) 6,967,208 9,326,945
Novartis Pharms. Corp. v. Breckenridge Pharm., Inc., 17-0420 (D. Del.) Apr. 13, 2017 Hon. Richard G. Andrews Affinitor® (everolimus tablets) 5,665,772 8,410,131 8,778,962
Millennium Pharms., Inc. v. Amneal Pharms. LLC, 17-0422 (D. Del.) Apr. 13, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446 6,958,319
Millennium Pharms., Inc. v. Zydus Pharms. (USA) Inc., 17-0423 (D. Del.) Apr. 13, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446 6,958,319
Bristol-Myers Squibb Co. v. Prinston Pharm. Inc., 17-0426 (D. Del.) Apr. 13, 2017 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 9,326,945
Eli Lilly and Co. v. Dr. Reddy’s Labs., Inc., 17-2541 (D.N.J.) Apr. 13, 2017 Hon. Kevin McNulty Cialis® (tadalafil tablets) 6,943,166
Sucampo AG v. Amneal Pharms. LLC, 17-2577 (D.N.J.) Apr. 13, 2017 Hon. Peter G. Sheridan Amitiza® (lubiprostone capsules) 6,982,283 8,097,653 8,389,542 8,026,393 8,338,639
Eli Lilly and Co. v. Par Pharm., Inc., 17-1219 (S.D. Ind.) Apr. 18, 2017 Hon. William T. Lawrence Axiron® (testosterone metered transdermal solution) 8,435,944 8,993,520 9,180,194 8,419,307 8,177,449 8,807,861 9,289,586
AstraZeneca Pharms. LP v. HBT Labs., Inc., 17-2652 (D.N.J.) Apr. 18, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122 7,456,160 8,329,680 8,466,139
Par Pharm., Inc. v. Sumitomo Dainippon Pharma Co., Ltd., IPR2017-01292 (PTAB) Apr. 18, 2017 N/A Latuda® (lurasidone hydrochloride tablets) 9,555,027
Ferring Pharms. Inc. v. Teva Pharms. USA, Inc., 17-0435 (D. Del.) Apr. 19, 2017 Hon. Richard G. Andrews Prepopik® (sodium picosulfate / magnesium oxide / citric acid oral solution) 8,450,338 8,481,083
Meda Pharms. Inc. v. Akorn, Inc., 17-0439 (D. Del.) Apr. 19, 2017 Hon. Gregory M. Sleet Astepro® (azelastine HCl nasal spray) 8,071,073 8,518,919
Onyx Therapeutics, Inc. v. Teva Pharms. USA, Inc., 17-0449 (D. Del.) Apr. 20, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042 7,232,818 7,491,704 7,737,112 8,129,346 8,207,125 8,207,126 8,207,127 8,207,297
Purdue Pharma L.P. v. Abhai, LLC, 17-0450 (D. Del.) Apr. 20, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,492,389 9,492,391 9,492,392 9,492,393 9,522,919
Amneal Pharms. LLC v. Pfizer Inc., 17-0454 (D. Del.) Apr. 20, 2017 Vacant Judgeship (2017) Zithromax® (azithromycin oral suspension) 6,268,489
Eli Lilly and Co. v. Par Pharm., Inc., 17-0456 (D. Del.) Apr. 21, 2017 Hon. Leonard P. Stark Axiron® (testosterone metered transdermal solution) 8,435,944 8,993,520 9,180,194 8,419,307 8,177,449 8,807,861 9,289,586
Bayer Intellectual Property GMBH v. Taro Pharm. Indus. Ltd., 17-0462 (D. Del.) Apr. 21, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Purdue Pharms. LP v. Collegium Pharm., Inc., 17-10690 (D. Mass.) Apr. 21, 2017 Hon. F. Dennis Saylor, IV OxyContin® (oxycodone HCl extended-release tablets) 9,522,919
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 17-2754 (D.N.J.) Apr. 21, 2017 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Allergan Sales, LLC v. Teva Pharms. USA, Inc., 17-0343 (E.D. Tex.) Apr. 21, 2017 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Galderma Labs., L.P. v. Actavis Labs UT, Inc., 17-1076 (N.D. Tex.) Apr. 21, 2017 Hon. Barbara M.G. Lynn Soolantra® (ivermectin cream) 8,362,069 8,815,816 9,089,587 9,233,117 9,233,118
Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., 17-2877 (D.N.J.) Apr. 26, 2017 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 9,561,177
Ferring Pharms. Inc. v. Serenity Pharms., LLC, 17-0479 (D. Del.) Apr. 28, 2017 Hon. Gregory M. Sleet Noctiva® (desmopressin acetate nasal spray) 7,405,203 7,579,321 7,799,761
Bayer Intellectual Property GMBH v. Aurobindo Pharma Ltd., 17-0483 (D. Del.) Apr. 28, 2017 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Celgene Corp. v. Par Pharm., Inc., 17-3159 (D.N.J.) 4-May-17 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 8,198,262 8,673,939 8,735,428 8,828,427
Helsinn Healthcare S.A. v. Virtus Pharms., LLC, 17-3216 (D.N.J.) 4-May-17 Hon. Mary L. Cooper Aloxi® (palonosetron HCl for injection) 7,947,724 7,947,725 7,960,424 8,598,219 8,729,094
Depomed, Inc. v. Strides Pharma, Inc., 17-3180 (D.N.J.) 5-May-17 Hon. Jose L. Linares Zipsor® (diclofenac potassium capsules) 7,662,858 7,884,095 7,939,518 8,110,606 8,623,920 9,561,200
Takeda Pharm. Co. Ltd. v. Torrent Pharms. Ltd., 17-3186 (D.N.J.) 5-May-17 Hon. Stanley R. Chesler Nesina® (alogliptin benzoate tablets) Oseni® (alogliptin benzoate / pioglitazone HCl tablets) Kazano® (alogliptin benzoate / metformin HCl tablets) 7,807,689 8,173,663 8,288,539 8,900,638
Rhodes Pharms. L.P. v. Ascent Pharms. Inc., 17-2755 (E.D.N.Y.) 5-May-17 Hon. Pamela K. Chen Dilaudid® (hydromorphone HCl oral solution) 6,589,960
Astellas Pharma Inc. v. Roxane Labs., Inc., 17-0542 (D. Del.) 9-May-17 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517 8,183,274 9,126,941
Impax Labs., Inc. v. Actavis Labs. FL, Inc., 17-3295 (D.N.J.) 9-May-17 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa capsules) 9,533,046
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 17-3342 (D.N.J.) 11-May-17 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,539,335
Celgene Corp. v. Hetero Labs Ltd., 17-3387 (D.N.J.) 11-May-17 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 8,198,262 8,673,939 8,735,428 8,828,427
Novo Nordisk Inc. v. Glenmark Pharms. Ltd., 17-3462 (D.N.J.) 11-May-17 Hon. Michael A. Shipp Vagifem® (estradiol vaginal tablets) 7,018,992
Bayer Intellectual Property GMBH v. Micro Labs Ltd., 17-0560 (D. Del.) 12-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Argentum Pharms. LLC v. Kaken Pharm. Co., Ltd., IPR2017-01429 (PTAB) 12-May-17 N/A Jublia® (efinaconazole topical solution) 7,214,506
Micro Labs Ltd. v. Santen Pharm. Co., Ltd., IPR2017-01434 (PTAB) 12-May-17 N/A Zioptan® (tafluprost ophthalmic solution) 5,886,035
Taro Pharms. U.S.A., Inc. v. Apotex Technologies, Inc., IPR2017-01446 (PTAB) 17-May-17 N/A Ferriprox® (deferiprone oral solution/tablets) 7,049,328
Bayer Intellectual Property GMBH v. Mylan Pharms. Inc., 17-0584 (D. Del.) 19-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Genzyme Corp. v. Ingenus Pharms. LLC, 17-0602 (D. Del.) 24-May-17 Hon. Leonard P. Stark Clolar® (clofarabine for injection) 5,661,136
Acorda Therapeutics, Inc. v. Micro Labs Ltd., 17-3724 (D.N.J.) 24-May-17 Hon. Brian R. Martinotti Ampyra® (dalfampridine extended-release tablets) 8,007,826 8,354,437 8,440,703 8,663,685
Bayer Intellectual Property GMBH v. Sigmapharm Labs., LLC, 17-0648 (D. Del.) 26-May-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Upsher-Smith Labs., Inc. v. Glenmark Pharms. Ltd., 17-0649 (D. Del.) 26-May-17 Vacant Judgeship (2017) Qudexy® XR (topiramate extended-release capsules) 8,652,527 8,889,190 9,101,545 9,555,005
Mallinckrodt IP v. B. Braun Medical Inc., 17-0660 (D. Del.) 31-May-17 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012 9,610,265
Allergan Inc. v. Taro Pharm. Industries Ltd., 17-0663 (D. Del.) 1-Jun-17 Vacant Judgeship (2017) Aczone® (dapsone gel) 9,517,219
Osi Pharms., LLC v. Hetero USA Inc., 17-0665 (D. Del.) 1-Jun-17 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Osi Pharms., LLC v. Sun Pharms. Industries Inc., 17-0666 (D. Del.) 1-Jun-17 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Forest Labs., LLC v. Macleods Pharms., Ltd., 17-0672 (D. Del.) 2-Jun-17 Hon. Leonard P. Stark Namenda XR® (memantine HCl extended-release capsules) 8,039,009 8,168,209 8,173,708 8,283,379
Forest Labs., LLC v. Macleods Pharms., Ltd., 17-0673 (D. Del.) 2-Jun-17 Hon. Leonard P. Stark Namzaric® (memantine HCl / donepezil HCl extended-release capsules) 8,039,009 8,058,291 8,338,485 8,338,486 8,580,858
Mallinckrodt IP v. B. Braun Medical Inc., 17-2474 (E.D. Pa.) 2-Jun-17 Hon. Jeffrey L. Schmehl Ofirmev® (acetaminophen for injection) 9,399,012 9,610,265
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 17-0677 (D. Del.) 5-Jun-17 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets) 9,486,412 9,486,413 9,492,389 9,492,390 9,492,391 9,545,380 9,517,236 9,572,779 9,572,804
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland GMBH, IPR2017-01526 (PTAB) 5-Jun-17 N/A Lantus® (insulin glargine recombinant for injection) 7,476,652
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland GMBH, IPR2017-01528 (PTAB) 5-Jun-17 N/A Lantus® (insulin glargine recombinant for injection) 7,713,930
Pfizer Inc. v. Macleods Pharms., Ltd., 17-0683 (D. Del.) 6-Jun-17 Hon. Richard G. Andrews Viagra® (sildenafil citrate tablets) 6,469,012
Amgen Inc. v. Piramal Healthcare UK Ltd., 17-0713 (D. Del.) 9-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
AstraZeneca LP v. Apotex Inc., 17-0714 (D. Del.) 9-Jun-17 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) RE46,276 7,250,419 7,265,124
Argentum Pharms. LLC v. Novartis A.G., IPR2017-01550 (PTAB) 9-Jun-17 N/A Gilenya® (fingolimod capsules) 9,187,405
Par Pharm., Inc. v. MonoSol Rx, LLC, IPR2017-01557 (PTAB) 9-Jun-17 N/A Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 8,603,514
Noden Pharma DAC v. Anchen Pharms., Inc., 17-0728 (D. Del.) 12-Jun-17 Vacant Judgeship (2017) Tekturna® (aliskiren hemifumarate tablets) 8,617,595
Kowa Co., Ltd. v. Hetero Drugs Ltd., 17-4421 (S.D.N.Y.) 12-Jun-17 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 8,557,993
Dr. Reddy’s Labs. S.A. v. MonoSol Rx, LLC, IPR2017-01582 (PTAB) 12-Jun-17 N/A Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 8,603,514
Breckenridge Pharm., Inc. v. Novartis Pharms. Corp., IPR2017-01592 (PTAB) 12-Jun-17 N/A Afinitor® (everolimus tablets) 8,410,131
Orexo AB v. Actavis Elizabeth LLC, 17-0758 (D. Del.) 14-Jun-17 Hon. Gregory M. Sleet Zubsolv® (buprenorphine HCl / naloxone HCl dehydrate sublingual tablets) 9,259,421 8,940,330
Kowa Co., Ltd. v. Hetero Drugs Ltd., 17-0762 (D. Del.) 14-Jun-17 Hon. Gregory M. Sleet Livalo® (pitavastatin calcium tablets) 8,557,993
Cosmo Technologies Ltd. v. Sun Pharm. Industries, Ltd., 17-4393 (D.N.J.) 15-Jun-17 Hon. Peter G. Sheridan Uceris® (budesonide extended-release tablets) 9,320,716
Belcher Pharms., LLC v. Hospira, Inc., 17-0775 (D. Del.) 19-Jun-17 Hon. Leonard P. Stark Abboject® (epinephrine for injection) 9,283,197
Omeros Corp. v. Sandoz Inc., 17-0799 (D. Del.) 21-Jun-17 Hon. Richard G. Andrews Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Omeros Corp. v. Sandoz Inc., 17-4564 (D.N.J.) 21-Jun-17 Hon. Brian R. Martinotti Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Watson Labs., Inc. v. United Therapeutics, Inc., IPR2017-01621 (PTAB) 21-Jun-17 N/A Tyvaso® (treprostinil solution for inhalation) 9,358,240
Watson Labs., Inc. v. United Therapeutics, Inc., IPR2017-01622 (PTAB) 21-Jun-17 N/A Tyvaso® (treprostinil solution for inhalation) 9,339,507
Omeros Corp. v. Lupin Ltd., 17-0803 (D. Del.) 22-Jun-17 Hon. Richard G. Andrews Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Omeros Corp. v. Lupin Ltd., 17-4595 (D.N.J.) 22-Jun-17 Hon. Brian R. Martinotti Omidria® (phenylephrine / ketorolac for injection) 8,173,707 8,586,633 9,066,856 9,278,101 9,399,040 9,486,406
Aurobindo Pharma USA Inc. v. Andrx Corp., IPR2017-01648 (PTAB) 22-Jun-17 N/A Fortamet® (metformin HCl extended-release tablets) Actoplus® Met XR (metformin HCl / pioglitazone HCl extended-release tablets) 6,866,866
Teijin Ltd. v. Indoco Remedies Ltd., 17-0809 (D. Del.) 23-Jun-17 Vacant Judgeship (2017) Uloric® (febuxostat tablets) 7,361,676 8,372,872 9,107,912
Bayer Intellectual Property GMBH v. Invagen Pharms., Inc., 17-0812 (D. Del.) 23-Jun-17 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Amgen Inc. v. Alkem Labs. Ltd., 17-0815 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Lupin Ltd., 17-0816 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Macleods Pharms., Ltd., 17-0817 (D. Del.) 23-Jun-17 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Aurobindo Pharma USA Inc. v. Andrx Corp., IPR2017-01673 (PTAB) 23-Jun-17 N/A Fortamet® (metformin HCl extended-release tablets) Actoplus® Met XR (metformin HCl / pioglitazone HCl extended-release tablets) 6,790,459
Biogen Int’l GMBH v. Amneal Pharms. LLC, 17-0823 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,399,514
Biogen Int’l GMBH v. Aurobindo Pharma U.S.A., Inc., 17-0824 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Hetero USA Inc., 17-0825 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen MA Inc. v. Impax Labs., Inc., 17-0826 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Prinston Pharm. Inc., 17-0827 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Slayback Pharma LLC, 17-0828 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen Int’l GMBH v. Teva Pharms. USA, Inc., 17-0829 (D. Del.) 26-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Concert Pharms., Inc. v. Incyte Corp., PGR2017-00034 (PTAB) 27-Jun-17 N/A Jakafi® (ruxolitinib phosphate tablets) 9,662,335
Biogen MA Inc. v. MSN Labs. Private Ltd, 17-0845 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Graviti Pharms Pvt. Ltd, 17-0846 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Shilpa Medicare Ltd., 17-0847 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Sun Pharma Global FZE, 17-0848 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen MA Inc. v. Windlas Healthcare, Pvt. Ltd., 17-0849 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Biogen Int’l GMBH v. Alkem Labs. Ltd., 17-0850 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Cipla Ltd., 17-0851 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Glenmark Pharms. Ltd., 17-0852 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Lupin Atlantis Holdings SA, 17-0853 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Torrent Pharms. Ltd., 17-0854 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Pharmathen S.A., 17-0855 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. TWi Pharms., Inc., 17-0856 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Macleods Pharms., Ltd., 17-0857 (D. Del.) 28-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Sebela Int’l Ltd. v. Actavis Labs. FL, Inc., 17-4789 (D.N.J.) 28-Jun-17 Hon. Claire C. Cecchi Brisdelle® (paroxetine capsules) 9,393,237
Biogen Int’l GMBH v. Stason Pharms., Inc., 17-1133 (C.D. Cal.) 30-Jun-17 Hon. Douglas F. McCormick Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. Sandoz Inc., 17-1606 (D. Col.) 30-Jun-17 Hon. Michael E. Hegarty Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Forest Labs., LLC v. Sun Pharma Global FZE, 17-0865 (D. Del.) 30-Jun-17 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 8,933,030
Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 17-0867 (D. Del.) 30-Jun-17 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
Biogen Int’l GMBH v. Accord Healthcare Inc., 17-0872 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Par Pharm., Inc., 17-0873 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Sandoz Inc., 17-0874 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Sawai USA, Inc., 17-0875 (D. Del.) 30-Jun-17 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514
Biogen Int’l GMBH v. Accord Healthcare Inc., 17-0612 (M.D.N.C.) 30-Jun-17 Hon. William L. Osteen, Jr. Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 8,399,514
Biogen Int’l GMBH v. Zydus Pharms. (USA) Inc., 17-4857 (D.N.J.) 30-Jun-17 Hon. Brian R. Martinotti Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Par Pharm., Inc., 17-4984 (S.D.N.Y.) 30-Jun-17 Hon. Jesse M. Furman Tecfidera® (dimethyl fumarate delayed-release capsules) 7,320,999 8,399,514
Biogen Int’l GMBH v. Mylan Pharms. Inc., 17-0116 (N.D.W.V.) 30-Jun-17 Hon. Irene M. Keeley Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376 7,320,999 7,619,001 7,803,840 8,759,393 8,399,514

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.